sign in sign up
<<
Home , Diacetyldihydromorphine, MMDA (drug)

1 Amending Synthetic Control Act 2 3 4 Summary 5 Amends ineffective law that simply address the problem of synthetic by passing legislation to make 6 specific chemical formulations of synthetic drugs illegal. These specific chemical formulations become 7 dated quickly. This bill goes after broad base formulations that create or mimic the effect of cannabis or 8 certain controlled substances and thereby helps law enforcement to stay ahead of criminal drug activity. 9 Additionally it addresses weakness in the Analog statute that allows clever distributors to cloak products 10 with an innocuous name in order to insulate themselves by marking packages: “Not For Human 11 Consumption.” 12 13 Model Legislation 14 15 Section 1. Short Title. Amending Synthetic Drug Control 16 17 Section 2. Purpose. Adds various synthetic drug compounds including various structural classes of those 18 compounds to the list of Schedule I controlled substances. Deletes from the definition of controlled 19 substance analog the requirement that a substance must be intended for human consumption to be 20 considered an analog of a controlled substance with a chemical structure substantially similar to that of a 21 controlled substance in Schedule I or II, or that was specifically designed to produce an effect substantially 22 similar to that of a controlled substance in Schedule I or II. 23 24 Section 3. Definition. 25 (f) "Controlled Substance" means (i) a drug, substance, or 26 immediate precursor, or synthetic drug in the Schedules of 27 Article II of this Act or (ii) a drug or other substance, or 28 immediate precursor, designated as a controlled substance by 29 30 the Department through administrative rule. The term does not 31 include distilled spirits, wine, malt beverages, or tobacco, as terms are defined or used in… (Reference 32 local state definitions of terms) 33 34 35 36 Section 4. Amending Synthetic Drug Control Act. 37 Sec. 204. 38 (a) The controlled substances listed in this 39 Section are included in Schedule I. 40 (b) Unless specifically excepted or unless listed in 41 another schedule, any of the following , including their 42 isomers, esters, ethers, salts, and salts of isomers, esters, 43 and ethers, whenever the existence of such isomers, esters, 44 ethers and salts is possible within the specific chemical 45 designation: 46 (1) Acetylmethadol; 47 (1.1) Acetyl-alpha-methylfentanyl 48 (N-[1-(1-methyl-2-phenethyl)- 49 4-piperidinyl]-N-phenylacetamide); 50 (2) Allylprodine; 51 (3) Alphacetylmethadol, except 52 levo-alphacetylmethadol (also known as levo-alpha- 53 acetylmethadol, levomethadyl acetate, or LAAM); 54 (4) Alphameprodine; 55 (5) Alphamethadol; 56 (6) Alpha-methylfentanyl 57 (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl) 58 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- 59 propanilido) piperidine; 60 (6.1) Alpha-methylthiofentanyl 61 62 (N-[1-methyl-2-(2-thienyl)ethyl- 63 4-piperidinyl]-N-phenylpropanamide); 64 (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP); 65 (7.1) PEPAP 66 (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); 67 (8) Benzethidine; 68 (9) Betacetylmethadol; 69 (9.1) Beta-hydroxyfentanyl 70 (N-[1-(2-hydroxy-2-phenethyl)- 71 4-piperidinyl]-N-phenylpropanamide); 72 (10) Betameprodine; 73 (11) Betamethadol; 74 (12) Betaprodine; 75 (13) Clonitazene; 76 (14) ; 77 (15) Diampromide; 78 (16) Diethylthiambutene; 79 (17) Difenoxin; 80 (18) ; 81 (19) Dimepheptanol; 82 (20) Dimethylthiambutene; 83 (21) Dioxaphetylbutyrate; 84 (22) ; 85 (23) Ethylmethylthiambutene; 86 (24) Etonitazene; 87 (25) Etoxeridine; 88 89 (26) Furethidine; 90 (27) Hydroxpethidine; 91 (28) ; 92 (29) Levomoramide; 93 (30) Levophenacylmorphan; 94 (31) 3-Methylfentanyl 95 (N-[3-methyl-1-(2-phenylethyl)- 96 4-piperidyl]-N-phenylpropanamide); 97 (31.1) 3-Methylthiofentanyl 98 (N-[(3-methyl-1-(2-thienyl)ethyl- 99 4-piperidinyl]-N-phenylpropanamide); 100 (32) Morpheridine; 101 (33) Noracymethadol; 102 (34) Norlevorphanol; 103 (35) Normethadone; 104 (36) Norpipanone; 105 (36.1) Para-fluorofentanyl 106 (N-(4-fluorophenyl)-N-[1-(2-phenethyl)- 107 4-piperidinyl]propanamide); 108 (37) Phenadoxone; 109 (38) Phenampromide; 110 (39) Phenomorphan; 111 (40) Phenoperidine; 112 (41) ; 113 (42) Proheptazine; 114 (43) Properidine; 115 116 (44) ; 117 (45) Racemoramide; 118 (45.1) Thiofentanyl 119 (N-phenyl-N-[1-(2-thienyl)ethyl- 120 4-piperidinyl]-propanamide); 121 (46) ; 122 (47) Trimeperidine; 123 (48) Beta-hydroxy-3-methylfentanyl (other name: 124 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]- 125 N-phenylpropanamide). 126 (c) Unless specifically excepted or unless listed in 127 another schedule, any of the following derivatives, its 128 salts, isomers and salts of isomers, whenever the existence of 129 such salts, isomers and salts of isomers is possible within the 130 specific chemical designation: 131 (1) Acetorphine; 132 (2) ; 133 (3) ; 134 (4) methylbromide; 135 (5) Codeine-N-Oxide; 136 (6) ; 137 (7) ; 138 (8) Diacetyldihydromorphine (Dihydroheroin); 139 (9) ; 140 (10) Drotebanol; 141 (11) (except hydrochloride salt); 142 143 (12) ; 144 (13) ; 145 (14) Methyldesorphine; 146 (15) Methyldihydromorphine; 147 (16) methylbromide; 148 (17) Morphine methylsulfonate; 149 (18) Morphine-N-Oxide; 150 (19) Myrophine; 151 (20) ; 152 (21) ; 153 (22) Normorphine; 154 (23) Pholcodine; 155 (24) . 156 (d) Unless specifically excepted or unless listed in 157 another schedule, any material, compound, mixture, or 158 preparation which contains any quantity of the following 159 hallucinogenic substances, or which contains any of its salts, 160 isomers and salts of isomers, whenever the existence of such 161 salts, isomers, and salts of isomers is possible within the 162 specific chemical designation (for the purposes of this 163 paragraph only, the term "isomer" includes the optical, 164 position and geometric isomers): 165 (1) 3,4-methylenedioxyamphetamine 166 (alpha-methyl,3,4-methylenedioxyphenethylamine, 167 methylenedioxyamphetamine, MDA); 168 (1.1) Alpha-ethyltryptamine 169 170 (some trade or other names: etryptamine; 171 MONASE; alpha-ethyl-1H-indole-3-ethanamine; 172 3-(2-aminobutyl)indole; a-ET; and AET); 173 (2) 3,4-methylenedioxymethamphetamine (MDMA); 174 (2.1) 3,4-methylenedioxy-N-ethylamphetamine 175 (also known as: N-ethyl-alpha-methyl- 176 3,4(methylenedioxy) , N-ethyl MDA, MDE, 177 and MDEA); 178 (2.2) N- (BZP); 179 (2.2-1) Trifluoromethylphenylpiperazine (TFMPP); 180 (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA); 181 (4) 3,4,5- (TMA); 182 (5) (Blank); 183 (6) (DET); 184 (7) Dimethyltryptamine (DMT); 185 (7.1) 5-Methoxy-diallyltryptamine; 186 (8) 4-methyl-2,5- (DOM, STP); 187 (9) (some trade and other names: 188 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy- 189 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] 190 indole; Tabernanthe iboga); 191 (10) Lysergic acid diethylamide; 192 (10.1) ; 193 (10.5) (meaning all parts of the plant 194 presently classified botanically as Salvia divinorum, 195 whether growing or not, the seeds thereof, any extract from 196 any part of that plant, and every compound, manufacture, 197 salts, isomers, and salts of isomers whenever the existence 198 of such salts, isomers, and salts of isomers is possible 199 within the specific chemical designation, derivative, 200 mixture, or preparation of that plant, its seeds or 201 extracts); 202 (11) 3,4,5-trimethoxyphenethylamine (); 203 (12) Peyote (meaning all parts of the plant presently 204 classified botanically as Lophophora williamsii Lemaire, 205 whether growing or not, the seeds thereof, any extract from 206 any part of that plant, and every compound, manufacture, 207 salts, derivative, mixture, or preparation of that plant, 208 its seeds or extracts); 209 (13) N-ethyl-3-piperidyl benzilate (JB 318); 210 (14) N-methyl-3-piperidyl benzilate; 211 (14.1) N-hydroxy-3,4-methylenedioxyamphetamine 212 (also known as N-hydroxy-alpha-methyl- 213 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA); 214 (15) ; some trade or other names: 215 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H- 216 dibenzo (b,d) pyran; Synhexyl; 217 (16) ; 218 (17) Psilocyn; 219 (18) Alpha-methyltryptamine (AMT); 220 (19) 2,5-dimethoxyamphetamine 221 (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA); 222 223 (20) 4-bromo-2,5-dimethoxyamphetamine 224 (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 225 4-bromo-2,5-DMA); 226 (20.1) 4-Bromo-2,5 dimethoxyphenethylamine. 227 Some trade or other names: 2-(4-bromo- 228 2,5-dimethoxyphenyl)-1-aminoethane; 229 alpha-desmethyl DOB, 2CB, Nexus; 230 (21) 4-methoxyamphetamine 231 (4-methoxy-alpha-methylphenethylamine; 232 paramethoxyamphetamine; PMA); 233 (22) (Blank); 234 (23) Ethylamine analog of . 235 Some trade or other names: 236 N-ethyl-1-phenylcyclohexylamine, 237 (1-phenylcyclohexyl) ethylamine, 238 N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE; 239 (24) Pyrrolidine analog of phencyclidine. Some trade 240 or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy, 241 PHP; 242 (25) 5-methoxy-3,4-methylenedioxy-; 243 (26) 2,5-dimethoxy-4-ethylamphetamine 244 (another name: DOET); 245 (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine 246 (another name: TCPy); 247 (28) (Blank); 248 (29) Thiophene analog of phencyclidine (some trade 249 250 or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 251 2-thienyl analog of phencyclidine; TPCP; TCP); 252 (30) Bufotenine (some trade or other names: 253 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole; 254 3-(2-dimethylaminoethyl)-5-indolol; 255 5-hydroxy-N,N-dimethyltryptamine; 256 N,N-dimethylserotonin; mappine); 257 (31) 1-Pentyl-3-(1-naphthoyl)indole 258 Some trade or other names: JWH-018; 259 (32) 1-Butyl-3-(1-naphthoyl)indole 260 Some trade or other names: JWH-073; 261 (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 262 (2-iodophenyl)methanone 263 Some trade or other names: AM-694; 264 (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 265 (2-methyloctan-2-yl)phenol 266 Some trade or other names: CP 47,497 267 and its C6, C8 and C9 homologs; 268 (34.5) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 269 (2-methyloctan-2-yl)phenol), where side chain n=5; 270 and homologues where side chain n=4, 6, or 7; Some 271 trade or other names: CP 47,497; 272 (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- 273 (2-methyloctan-2-yl)-6a,7, 274 10,10a-tetrahydrobenzo[c]chromen-1-ol 275 Some trade or other names: HU-210; 276 277 (35.5) (6aS,10aS)-9-(hydroxymethyl)-6,6- 278 dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 279 tetrahydrobenzo[c]chromen-1-ol, its isomers, 280 salts, and salts of isomers; Some trade or other 281 names: HU-210, Dexanabinol; 282 (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)- 283 6,6-dimethyl-3-(2-methyloctan-2-yl)- 284 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 285 Some trade or other names: HU-211; 286 (37) (2-methyl-1-propyl-1H-indol- 287 3-yl)-1-naphthalenyl-methanone 288 Some trade or other names: JWH-015; 289 (38) 4-methoxynaphthalen-1-yl- 290 (1-pentylindol-3-yl)methanone 291 Some trade or other names: JWH-081; 292 (39) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole 293 Some trade or other names: JWH-122; 294 (40) 2-(2-methylphenyl)-1-(1-pentyl- 295 1H-indol-3-yl)-ethanone 296 Some trade or other names: JWH-251; 297 (41) 1-(2-cyclohexylethyl)-3- 298 (2-methoxyphenylacetyl)indole 299 Some trade or other names: RCS-8, BTW-8 and SR-18; 300 (42) Any compound structurally derived from 301 3-(1-naphthoyl)indole or 1H-indol-3-yl- 302 (1-naphthyl)methane by substitution at the 303 304 nitrogen atom of the indole ring by alkyl, haloalkyl, 305 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide, 306 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, 307 or 2-(4-morpholinyl)ethyl whether or not further 308 substituted in the indole ring to any extent, whether 309 or not substituted in the naphthyl ring to any extent. 310 Examples of this structural class include, but are 311 not limited to, JWH-018, AM-2201, JWH-175, JWH-184, 312 and JWH-185; 313 (43) Any compound structurally derived from 314 3-(1-naphthoyl)pyrrole by substitution at the nitrogen 315 atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 316 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl 317 aryl halide, 1-(N-methyl-2-piperidinyl)methyl, 318 or 2-(4-morpholinyl)ethyl, whether or not further 319 substituted in the pyrrole ring to any extent, whether 320 or not substituted in the naphthyl ring to any extent. 321 Examples of this structural class include, but are not 322 limited to, JWH-030, JWH-145, JWH-146, JWH-307, and 323 JWH-368; 324 (44) Any compound structurally derived from 325 1-(1-naphthylmethyl)indene by substitution 326 at the 3-position of the indene ring by alkyl, haloalkyl, 327 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 328 halide, alkyl aryl halide, 1-(N-methyl- 329 2-piperidinyl)methyl, or 2-(4- 330 331 morpholinyl)ethyl whether or not further substituted in 332 the indene ring to any extent, whether or not substituted 333 in the naphthyl ring to any extent. Examples of 334 this structural class include, but are not 335 limited to, JWH-176; 336 (45) Any compound structurally derived from 337 3-phenylacetylindole by substitution at the 338 nitrogen atom of the indole ring with alkyl, haloalkyl, 339 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 340 halide, alkyl aryl halide, 1-(N-methyl-2- 341 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 342 whether or not further substituted in the indole ring 343 to any extent, whether or not substituted in the phenyl 344 ring to any extent. Examples of this structural 345 class include, but are not limited to, JWH-167, 346 JWH-250, JWH-251, and RCS-8; 347 (46) Any compound structurally derived from 348 2-(3-hydroxycyclohexyl)phenol by substitution 349 at the 5-position of the phenolic ring by alkyl, 350 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 351 aryl halide, alkyl aryl halide, 1-(N-methyl-2- 352 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 353 whether or not substituted in the cyclohexyl ring to any 354 extent. Examples of this structural class 355 include, but are not limited to, CP 47, 356 497 and its C8 homologue (cannabicyclohexanol); 357 358 (46.1) Benzoylindoles: Any compound 359 containing a 3-(benzoyl) indole structure with 360 substitution at the nitrogen atom of the 361 indole ring by an alkyl, haloalkyl, alkenyl, 362 cycloalkylmethyl, cycloalkylethyl, 363 1-(N-methyl-2-piperidinyl)methyl, 364 or 2-(4-morpholinyl)ethyl group 365 whether or not further substituted 366 in the indole ring to any extent and 367 whether or not substituted in the phenyl ring 368 to any extent. Examples of this structural class 369 include, but are not limited, to AM-630, 370 AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4; 371 (47) 3,4-Methylenedioxymethcathinone 372 Some trade or other names: ; 373 (48) 3,4-Methyenedioxypyrovalerone 374 Some trade or other names: MDPV; 375 (49) 4-Methylmethcathinone 376 Some trade or other names: ; 377 (50) 4-methoxymethcathinone; 378 (51) 4-Fluoromethcathinone; 379 (52) 3-Fluoromethcathinone; 380 (53) 2,5-Dimethoxy-4-(n)-propylthio- 381 phenethylamine; 382 (54) 5-Methoxy-N,N-; 383 (55) ; 384 385 (56) 4-iodo-2,5-dimethoxy-N-((2-methoxy 386 phenyl)methyl)-benzeneethanamine 387 (trade or other name: 25I-NBOMe); 388 (57) 4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl) 389 methyl]-benzeneethanamine (trade or other name: 390 25C-NBOMe); 391 (58) 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl) 392 methyl]-benzeneethanamine (trade or other name: 393 25B-NBOMe); . 394 (59) 3-cyclopropoylindole with 395 substitution at the nitrogen atom of the 396 indole ring by alkyl, haloalkyl, alkenyl, 397 cycloalkylmethyl, cycloalkylethyl, aryl 398 halide, alkyl aryl halide, 399 1-(N-methyl-2-piperidinyl)methyl, or 400 2-(4-morpholinyl)ethyl, whether or not 401 further substituted on the indole ring 402 to any extent, whether or not substituted 403 on the cyclopropyl ring to any extent: 404 including but not limited to XLR11, 405 UR144, FUB-144; 406 (60) 3-adamantoylindole with 407 substitution at the nitrogen atom of the 408 indole ring by alkyl, haloalkyl, alkenyl, 409 cycloalkylmethyl, cycloalkylethyl, 410 aryl halide, alkyl aryl halide, 411 412 1-(N-methyl-2-piperidinyl)methyl, or 413 2-(4-morpholinyl)ethyl, whether or not 414 further substituted on the indole ring to 415 any extent, whether or not substituted on 416 the adamantyl ring to any extent: including 417 but not limited to AB-001; 418 (61) N-(adamantyl)-indole-3-carboxamide 419 with substitution at the nitrogen atom of the 420 indole ring by alkyl, haloalkyl, alkenyl, 421 cycloalkylmethyl, cycloalkylethyl, aryl halide, 422 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, 423 or 2-(4-morpholinyl)ethyl, whether or not further 424 substituted on the indole ring to any extent, whether 425 or not substituted on the adamantyl ring to any 426 extent: including but not limited to 427 APICA/2NE-1, STS-135; 428 (62) N-(adamantyl)-indazole-3-carboxamide 429 with substitution at a nitrogen atom of the indazole 430 ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 431 cycloalkylethyl, aryl halide, alkyl aryl halide, 432 1-(N-methyl-2-piperidinyl)methyl, or 433 2-(4-morpholinyl)ethyl, whether or not further 434 substituted on the indazole ring to any extent, 435 whether or not substituted on the adamantyl 436 ring to any extent: including but not limited 437 to AKB48, 5F-AKB48; 438 439 (63) 1H-indole-3-carboxylic acid 8-quinolinyl 440 ester with substitution at the nitrogen atom of the 441 indole ring by alkyl, haloalkyl, alkenyl, 442 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl 443 aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 444 2-(4-morpholinyl)ethyl, whether or not further 445 substituted on the indole ring to any extent, 446 whether or not substituted on the quinoline ring 447 to any extent: including but not limited to PB22, 448 5F-PB22, FUB-PB-22; 449 (64) 3-(1-naphthoyl)indazole with 450 substitution at the nitrogen atom of the 451 indazole ring by alkyl, haloalkyl, 452 alkenyl, cycloalkylmethyl, cycloalkylethyl, 453 aryl halide, alkyl aryl halide, 454 1-(N-methyl-2-piperidinyl)methyl, or 455 2-(4-morpholinyl)ethyl, whether or not further 456 substituted on the indazole ring to any extent, 457 whether or not substituted on the naphthyl ring 458 to any extent: including but not limited to 459 THJ-018, THJ-2201; 460 (65) 2-(1-naphthoyl)benzimidazole with 461 substitution at the nitrogen atom of the benzimidazole 462 ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, 463 cycloalkylethyl, aryl halide, alkyl aryl halide, 464 1-(N-methyl-2-piperidinyl)methyl, or 465 466 2-(4-morpholinyl)ethyl, whether or not further 467 substituted on the benzimidazole ring to any extent, 468 whether or not substituted on the naphthyl ring to 469 any extent: including, but not limited to FUBIMINA; 470 (66) N-(1-amino-3-methyl-1-oxobutan-2-yl) 471 -1H-indazole-3-carboxamide with substitution on the 472 nitrogen atom of the indazole ring by alkyl, 473 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 474 aryl halide, alkyl aryl halide, 1-(N-methyl-2- 475 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 476 whether or not further substituted on the indazole 477 ring to any extent: including but not limited to 478 AB-PINACA, AB-FUBINACA, AB-CHMINACA; 479 (67) N-(1-amino-3,3-dimethyl-1-oxobutan- 480 2-yl)-1H-indazole-3-carboxamide with substitution 481 on the nitrogen atom of the indazole ring by alkyl, 482 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 483 aryl halide, alkyl aryl halide, 1-(N-methyl-2- 484 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, whether 485 or not further substituted on the indazole ring to any 486 extent: including but not limited to ADB-PINACA, 487 ADB-FUBINACA; 488 (68) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)- 489 1H-indole-3-carboxamide with substitution on the nitrogen 490 atom of the indole ring by alkyl, haloalkyl, alkenyl, 491 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl 492 493 aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or 494 2-(4-morpholinyl)ethyl, whether or not further 495 substituted on the indole ring to any extent: 496 including but not limited to ADBICA, 5F-ADBICA; 497 (69) N-(1-amino-3-methyl-1-oxobutan-2-yl)- 498 1H-indole-3-carboxamide with substitution on the 499 nitrogen atom of the indole ring by alkyl, haloalkyl, 500 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 501 halide, alkyl aryl halide, 1-(N-methyl-2- 502 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 503 whether or not further substituted on the indole 504 ring to any extent: including but not limited 505 to ABICA, 5F-ABICA; 506 (70) Methyl 2-(1H-indazole-3-carboxamido)- 507 3-methylbutanoate with substitution on the nitrogen 508 atom of the indazole ring by alkyl, haloalkyl, 509 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl 510 halide, alkyl aryl halide, 1-(N-methyl-2- 511 piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 512 whether or not further substituted on the indazole 513 ring to any extent: including but not limited to AMB, 514 5F-AMB. 515 (e) Unless specifically excepted or unless listed in 516 another schedule, any material, compound, mixture, or 517 preparation which contains any quantity of the following 518 substances having a depressant effect on the central nervous 519 520 system, including its salts, isomers, and salts of isomers 521 whenever the existence of such salts, isomers, and salts of 522 isomers is possible within the specific chemical designation: 523 (1) mecloqualone; 524 (2) methaqualone; and 525 (3) gamma hydroxybutyric acid. 526 (f) Unless specifically excepted or unless listed in 527 another schedule, any material, compound, mixture, or 528 preparation which contains any quantity of the following 529 substances having a effect on the central nervous 530 system, including its salts, isomers, and salts of isomers: 531 (1) ; 532 (2) N-ethylamphetamine; 533 (3) (some other names: 534 2-amino-5-phenyl-2-oxazoline; aminoxaphen; 535 4-5-dihydro-5-phenyl-2-oxazolamine) and its 536 salts, optical isomers, and salts of optical isomers; 537 (4) (some other names: 538 2-methylamino-1-phenylpropan-1-one; 539 Ephedrone; 2-(methylamino)-propiophenone; 540 alpha-(methylamino)propiophenone; N-methylcathinone; 541 methycathinone; Monomethylpropion; UR 1431) and its 542 salts, optical isomers, and salts of optical isomers; 543 (5) (some trade or other names: 544 2-aminopropiophenone; alpha-aminopropiophenone; 545 2-amino-1-phenyl-propanone; norephedrone); 546 547 (6) N,N- (also known as: 548 N,N-alpha-trimethyl-benzeneethanamine; 549 N,N-alpha-trimethylphenethylamine); 550 (7) (+ or -) cis-4-methylaminorex ((+ or -) cis- 551 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine); 552 (8) 3,4-Methylenedioxypyrovalerone (MDPV). 553 (g) Temporary listing of substances subject to emergency 554 scheduling. Any material, compound, mixture, or preparation 555 that contains any quantity of the following substances: 556 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide 557 (benzylfentanyl), its optical isomers, isomers, salts, 558 and salts of isomers; 559 (2) N-[1(2-thienyl) 560 methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), 561 its optical isomers, salts, and salts of isomers. 562 (h) Synthetic . Unless specifically excepted, 563 any chemical compound not including , structurally 564 derived from 2-aminopropan-1-one by substitution at the 565 1-position with either phenyl, naphthyl, or thiophene ring 566 systems, whether or not the compound is further modified in one 567 or more of the following ways: 568 (1) by substitution in the ring system to 569 any extent with alkyl, alkylenedioxy, alkoxy, 570 haloalkyl, hydroxyl, or halide substituents, whether 571 or not further substituted in the ring system 572 by one or more other univalent substituents. 573 574 Examples of this class include, but are not 575 limited to, 3,4- 576 (bk-MDA); 577 (2) by substitution at the 3-position 578 with an acyclic alkyl substituent. Examples of 579 this class include, but are not limited to, 580 2-methylamino-1-phenylbutan-1-one 581 (); or 582 (3) by substitution at the 2-amino nitrogen 583 atom with alkyl, dialkyl, benzyl, or methoxybenzyl 584 groups, or by inclusion of the 2-amino nitrogen atom 585 in a cyclic structure. Examples of this class include, 586 but are not limited to, Dimethylcathinone, , 587 and a-Pyrrolidinopropiophenone (a-PPP). 588 (Source: P.A. 97-192, eff. 7-22-11; 97-193, eff. 1-1-12; 589 97-194, eff. 7-22-11; 97-334, eff. 1-1-12; 97-813, eff. 590 7-13-12; 97-872, eff. 7-31-12; 98-987, eff. 1-1-15.) 591 592 Sec (Regarding Manufacture or Delivery of Controlled Synthetic drugs). 401. 593 Except as authorized by this Act, it is unlawful 594 for any person knowingly to manufacture or deliver, or possess 595 with intent to manufacture or deliver, a controlled substance 596 other than , a counterfeit substance, or a 597 controlled substance analog. A violation of this Act with 598 respect to each of the controlled substances listed herein 599 constitutes a single and separate violation of this Act. For 600 purposes of this Section, "controlled substance analog" or 601 "analog" means a substance which is intended for human 602 consumption, other than a controlled substance, that has a 603 chemical structure substantially similar to that of a 604 controlled substance in Schedule I or II, or that was 605 specifically designed to produce an effect substantially 606 similar to that of a controlled substance in Schedule I or II. 607 Examples of chemical classes in which controlled substance 608 analogs are found include, but are not limited to, the 609 following: , N-substituted piperidines, 610 morphinans, ecgonines, quinazolinones, substituted indoles, 611 and arylcycloalkylamines. For purposes of this Act, a 612 controlled substance analog shall be treated in the same manner 613 as the controlled substance to which it is substantially 614 similar. 615 616 Sec. 402 (Regarding Possession of Controlled Synthetic Drugs). 617 Except as otherwise authorized by this Act, it is 618 unlawful for any person knowingly to possess a controlled or 619 counterfeit substance or controlled substance analog. A 620 violation of this Act with respect to each of the controlled 621 substances listed herein constitutes a single and separate 622 violation of this Act. For purposes of this Section, 623 "controlled substance analog" or "analog" means a substance 624 which is intended for human consumption, other than a 625 controlled substance, that has a chemical structure 626 substantially similar to that of a controlled substance in 627 Schedule I or II, or that was specifically designed to produce 628 629 an effect substantially similar to that of a controlled 630 substance in Schedule I or II. Examples of chemical classes in 631 which controlled substance analogs are found include, but are 632 not limited to, the following: phenethylamines, N-substituted 633 piperidines, morphinans, ecgonines, quinazolinones, 634 substituted indoles, and arylcycloalkylamines. For purposes of 635 this Act, a controlled substance analog shall be treated in the 636 same manner as the controlled substance to which it is 637 substantially similar. 638 639 Section 5. Severability clause. 640 641 Section 6. Repealer clause. 642 643 Section 7. {Insert Effective Date}